Study on Human Vaccines for Oncogenic Viruses and Perspectives for Tumor Antigens Induced by Virus | Chapter 7 | Innovations in Medicine and Medical Research Vol.2
The
Variola major, the virus that causes the smallpox, lethal virus in the 30% of
the cases, was eraticated in 1979 in the human species, thanks to a capillary
vaccination on global scale. Recently the Word Health Organization (WHO)
declared that India and Southeast Asia are polio-free, really a great
achivement since the vaccine for polio, an infectious desease that can cause
paralysis, was certificated safe and useful only 60 years ago. The vaccine for
the virus, responsible for hepatitis B infection HBV, is able to prevent 50% of
all liver cancers. Human Papilloma Virus (HPV) have been correlated with the
cervical cancer (genotypes 16 and 18 particularly oncogenic in humans): the USA
Food and Drug Administration (FDA) in 2006 released the first vaccine against
HPV. Finally, the ability of the immune system to recognize a tumor-associated
antigen enables the development of a vaccine approach for therapeutic
application and represents a main target of this field of research. Long years
of research were required for busting new systems to fight cancer. Research is
going to obtain the complete sequence by proteomics approaches, in order to
achieve adequate antigen preparations that might be used to generate assays for
a specific anticancer vaccine.
Author(s) Details
Giulio Tarro
Beaumont Bonelli Foundation for Cancer Research, Naples, Italy and Committee on Biotechnologies and Virus Sphere, World Academy of Biomedical Technologies, UNESCO, Paris, France.
View Book :- http://bp.bookpi.org/index.php/bpi/catalog/book/161
Author(s) Details
Giulio Tarro
Beaumont Bonelli Foundation for Cancer Research, Naples, Italy and Committee on Biotechnologies and Virus Sphere, World Academy of Biomedical Technologies, UNESCO, Paris, France.
View Book :- http://bp.bookpi.org/index.php/bpi/catalog/book/161
Comments
Post a Comment